Figure 2.

PFS of patients at different stages of disease (A), different tumor response (B), and different changes in CA19‐9 levels (C) after treatment.

PFS of patients at different stages of disease (A), different tumor response (B), and different changes in CA19‐9 levels (C) after treatment.